Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02517294 · ClinicalTrials.gov registry record · NA
, "Mucosal Injury During Nasotracheal Intubation for Dental Procedures in Children-does the Tube Design Matter?"
A NA study of Epistaxis, sponsored by Nemours Children's Clinic.
- Completed
- Registry status
- NA
- Development phase
- 73
- Enrollment target
- 1
- Study location
NCT02517294: Completed NA study of Epistaxis, sponsored by Nemours Children's Clinic.
NCT02517294 is a NA study of Epistaxis that has completed, run by Nemours Children's Clinic. The registered enrollment target is 73 participants, below the 2,531-participant average among 4 other Epistaxis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02517294, a NA study of Epistaxis, has completed, sponsored by Nemours Children's Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 73 participants
- Enrollment target
- 1
- Study location
Study Summary
Comparison is made between standard nasotracheal tubes and a specially designed nasotracheal tube during nasotracheal intubation in children undergoing general anesthesia for dental surgery.
Primary Outcome
Mucosal damage as quantified by presence and severity of bleeding immediately after passage of the NTT through the nasopharynx.
Conditions Studied
Interventions
- DEVICE Parker flex-tip nasotracheal tube
- DEVICE Standard nasotracheal tube
Study Locations (1)
Florida
- Wolfson Children's Hospital - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2015-06 |
| Est. Completion | 2019-08 |
| Phase | NA |
What the finished NCT02517294 record still lists
NCT02517294 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 73 participants, a relatively small participant target, below the 2,531-participant average among 4 other Epistaxis trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Epistaxis appearing as the primary indexed condition, and to 2 interventions - of which Parker flex-tip nasotracheal tube is the first listed.
NCT02517294 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT02517294 about?
NCT02517294 is a clinical study titled ", "Mucosal Injury During Nasotracheal Intubation for Dental Procedures in Children-does the Tube Design Matter?"". Comparison is made between standard nasotracheal tubes and a specially designed nasotracheal tube during nasotracheal intubation in children undergoing general anesthesia for dental surgery.
What is the current status of trial NCT02517294?
This trial is currently completed. It is a NA study. The enrollment target is 73 participants. The study started on 2015-06. Estimated completion is 2019-08.
What conditions does trial NCT02517294 study?
This clinical trial studies the following conditions: Epistaxis.
What interventions are being tested in trial NCT02517294?
The interventions under investigation include: Parker flex-tip nasotracheal tube (DEVICE), Standard nasotracheal tube (DEVICE).
Who is sponsoring clinical trial NCT02517294?
This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02517294 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epistaxis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nasal Saline Irrigation After Radiation Therapy for Oropharyngeal Cancer
COMPLETED · NA
-
Comprehensive HHT Outcomes Registry of the United States (CHORUS)
RECRUITING
-
Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz)
ACTIVE NOT RECRUITING · Phase 2
-
Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03661307 · 73 participants · Phase 1
Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
- NCT05386108 · 73 participants · Phase 1
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- NCT05961592 · 73 participants · Phase 1
R-2487 in Patients With Rheumatoid Arthritis
- NCT06150664 · 73 participants · Phase 1
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia